Macrogol 4000 Aurobindo

Macrogol 4000, the active ingredient in Macrogol 4000 Aurobindo, is an osmotic laxative presented as a powder for oral use. It increases intestinal water content to soften stool and facilitate bowel movements in adults and children with constipation.

GNH USA supplies Macrogol 4000 Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to European Union quality standards and is available for global distribution to meet diverse healthcare needs. Our robust supply chain ensures timely delivery and regulatory compliance.

Macrogol 4000 is an osmotic laxative that acts on the gastrointestinal tract to relieve constipation and related disorders. - Constipation: softens stool, increases water content in the colon, and promotes regular bowel movements in patients with functional constipation. - Opioid‑induced constipation: counteracts opioid‑related reduction in intestinal motility, enhancing stool passage and reducing discomfort in patients receiving opioid therapy. - Chronic idiopathic constipation: improves stool frequency and consistency, aiding long‑term management of persistent constipation unresponsive to dietary measures. - Bowel preparation for diagnostic procedures: facilitates colon cleansing when used in appropriate regimens prior to colonoscopy.

Macrogol 4000 may cause several adverse reactions, ranging from mild to serious. Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Flatulence: increased passing of intestinal gas. - Diarrhea: loose, watery stools occurring more frequently than normal. Serious or Rare Side Effects: - Severe dehydration: excessive loss of body fluids leading to dizziness or fainting. - Electrolyte imbalance: abnormal levels of sodium, potassium or other ions. - Allergic reaction: rash, itching, swelling, or difficulty breathing.

Before using Macrogol 4000, consider the following precautions to ensure safe and effective therapy. - Assess hydration status: verify the patient is not severely dehydrated before initiating therapy. - Renal impairment: use with caution in patients with reduced kidney function. - Electrolyte monitoring: check serum electrolytes periodically during prolonged use. - Bowel obstruction: avoid in individuals with known intestinal blockage or perforation. - Dosage adherence: do not exceed the prescribed amount or duration. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Macrogol 4000 can interact with certain medicines, affecting their efficacy or safety. Major Interactions (Avoid): - Other osmotic laxatives: concurrent use may cause severe fluid loss and electrolyte disturbances. - Loop diuretics: combined effect can increase risk of dehydration and electrolyte imbalance. Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce the laxative effect of Macrogol 4000. - Mineral supplements (e.g., calcium, magnesium): can alter stool consistency and affect absorption. - NSAIDs: may increase risk of gastrointestinal irritation when used together.